Take Home Messages for Clinical Practice: Transforming First-Line Treatment of Advanced Non-Small Cell Lung Cancer

PROGRAM CHAIR

Debora S. Bruno MD, MS
Assistant Professor of Medicine
Medical Director, University Hospitals Dahms Clinical Research Unit
University Hospitals Cleveland Medical Center Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine
Cleveland, OH

David P. Carbone, MD, PhD
Professor of Internal Medicine
Director of the James Thoracic Oncology Center at the OSUMC
Barbara J. Bonner Chair in Lung Research
The Ohio State University
Columbus, OH

PROGRAM DESCRIPTION

This enduring educational activity will explore the management of advanced non-small cell lung cancer (NSCLC). The presentation including animations and case studies will discuss treatment options and management of the disease and will assess clinical trial data regarding efficacy and safety.

TARGET AUDIENCE

This activity is designed to meet the educational needs of medical oncologists, oncology nurses, pharmacists, nurse practitioners and other members of the multidisciplinary team to maintain an up-to-date understanding of the latest data on immune checkpoint inhibitor regimens in the management of NSCLC.

LEARNING OBJECTIVES

• Evaluate the application of clinical practice guidelines to the treatment of patients with advanced NSCLC and no targetable mutations
• Review the management of immune-related adverse events in patients with NSCLC treated with immunotherapies
• Discuss the trials findings for first-line, immunotherapy agents both as monotherapy and in combination in the management of patients with advanced NSCLC

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NURSES (ANCC) CREDIT DESIGNATION

Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIP(S)

Debora S. Bruno MD, MS	Consulting Fees	Amgen, Bristol Myers Squibb, Novartis, Eli Lilly, Daiichi-Sankyo, AstraZeneca, Mirati Therapeutics
	Contracted Research	Bristol Myers Squibb, Dragonfly Therapeutics, Mirati Therapeutics, Daiichi-Sankyo, AstraZeneca, Genentech, Seagen
David P. Carbone, MD, PhD	Consulting Fees	GSK, Iovance Biotherapeutics, Janssen, Jazz, JNJ, Merck/EMD Serono, Merck KGgA, Mirati, Novartis, Regeneron, Sanofi, Roche Taiwan, AZ, Pfizer, Arcus Biosciences, Roche, Bristol Myers Squibb Israel, AbbVie, MSD, Pfizer Egypt, Genentech

All relevant financial relationships have been mitigated.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff, Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:

• Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
• Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
• Michael Page, Medical Director for Med Learning Group, has nothing to disclose.
• Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
• Amanda Jenkins, Program Manager for Med Learning Group has nothing to disclose.
• Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
• Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Complete the online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group at [email protected]

RELEASED DATE: June 30, 2023
EXPIRATION DATE: June 30, 2024

Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.